Pharmacy benefit management.

California Assembly Bill 910 aims to update regulations related to pharmacy benefit management, which involves how prescription drugs are managed and reimbursed by insurance companies. The bill seeks to improve transparency and accountability in the pharmacy benefit management process, potentially benefiting consumers and healthcare providers. It amends existing sections of the Health and Safety Code to enhance oversight in this area.

Supporters of AB 910 argue that this legislation will lead to fairer practices in pharmacy benefit management, ultimately lowering costs for consumers and improving access to necessary medications. They believe that increased transparency will hold pharmaceutical companies and insurers accountable, ensuring that patients receive the best possible care.

Critics of AB 910 contend that the bill may impose excessive regulations on pharmacy benefit managers, which could lead to increased costs for insurance companies and, consequently, higher premiums for consumers. They argue that the legislation could stifle innovation in drug management and create administrative burdens that do not necessarily translate into better healthcare outcomes.